CD44 and ovarian carcinoma: In contrast, other studies have demonstrated that high CD44s expression is associated with improved ovarian cancer outcome [39–41], whilst other studies have found no association between CD44s or CD44 variant expression with ovarian cancer metastasis or survival outcome [74,78,79].